Immune-Mediated Necrotizing Myopathy
10 clinical trials · Condition
◉ Watch Immune-Mediated Necrotizing Myopathy
| Record | Firm | Date |
|---|---|---|
| Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial) (NCT04450654) | University of Washington | 2022-05-01 |
| Add-on Intravenous Immunoglobulins in Early Myositis (NCT05832034) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-09-13 |
| High-intensity Strength Training in Myositis (NCT04486261) | Rigshospitalet, Denmark | 2021-08-30 |
| Juvenile Autoimmune Necrotizing Myopathies (NCT04295785) | Central Hospital, Nancy, France | 2020-03-01 |
| Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy (NCT04025632) | Ra Pharmaceuticals | 2019-11-07 |
Track Immune-Mediated Necrotizing Myopathy automatically
Every clearance here is in the API, with alerts when new ones post.